{
    "root": "f9f34f4d-d49d-4921-9e3e-8b6e2fd16d9f",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Terbinafine Hydrochloride",
    "value": "20240207",
    "ingredients": [
        {
            "name": "TERBINAFINE HYDROCHLORIDE",
            "code": "012C11ZU6G"
        },
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4"
        },
        {
            "name": "HYPROMELLOSE, UNSPECIFIED",
            "code": "3NXW29V3WO"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "MICROCRYSTALLINE CELLULOSE",
            "code": "OP1R32D61U"
        },
        {
            "name": "SODIUM STARCH GLYCOLATE TYPE A POTATO",
            "code": "5856J3G2A2"
        }
    ],
    "indications": "terbinafine tablets indicated treatment onychomycosis toenail fingernail due dermatophytes ( tinea unguium ) . prior initiating treatment , appropriate nail specimens laboratory testing [ potassium hydroxide ( koh ) preparation , fungal culture , nail biopsy ] obtained confirm diagnosis onychomycosis .",
    "contraindications": "prior administering , evaluate patients evidence chronic active liver disease . ( 2.1 ) fingernail onychomycosis : one tablet , daily 6 weeks . ( 2.2 ) toenail onychomycosis : one tablet , daily 12 weeks . ( 2.2 )",
    "warningsAndPrecautions": "terbinafine tablets , usp supplied white , oblong , unscored tablets debossed `` b `` `` 526 `` one side plain side . ndc : 72162-1595-1 : 100 tablets bottle store terbinafine tablets , usp 20\u00b0 - 25\u00b0c ( 68\u00b0 - 77\u00b0f ) [ usp controlled room temperature ] . repackaged/relabeled : bryant ranch prepack , inc. burbank , ca 91504",
    "adverseReactions": "terbinafine tablets contraindicated patients : chronic active liver disease [ ( 5.1 ) ] history allergic reaction oral terbinafine risk anaphylaxis [ ( 6.2 ) ]",
    "indications_original": "Terbinafine tablets are indicated for the treatment of onychomycosis of the toenail or fingernail due to dermatophytes (tinea unguium). \n                  Prior to initiating treatment, appropriate nail specimens for laboratory testing [potassium hydroxide (KOH) preparation, fungal culture, or nail biopsy] should be obtained to confirm the diagnosis of onychomycosis.",
    "contraindications_original": "Prior to administering, evaluate patients for evidence of chronic or active liver disease. ( 2.1 ) Fingernail onychomycosis: One tablet, once daily for 6 weeks. ( 2.2 ) Toenail onychomycosis: One tablet, once daily for 12 weeks. ( 2.2 )",
    "warningsAndPrecautions_original": "Terbinafine Tablets, USP are supplied as white, oblong, unscored tablets debossed \"B\" and \"526\" on one side and plain on the other side.\n                  NDC: 72162-1595-1: 100 Tablets in a BOTTLE\n                  Store Terbinafine Tablets, USP at 20\u00b0 - 25\u00b0C (68\u00b0 - 77\u00b0F) [See USP Controlled Room Temperature].\n                  Repackaged/Relabeled by:\n                  Bryant Ranch Prepack, Inc.\n                  Burbank, CA 91504",
    "adverseReactions_original": "Terbinafine tablets are contraindicated in patients with:\n                  \n                     Chronic or active liver disease [see Warnings and Precautions (5.1)]\n                     \n                     History of allergic reaction to oral terbinafine because of the risk of anaphylaxis [see Adverse Reactions (6.2)]"
}